UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~March~~November 1014, 2014

~~Vansen~~VANSEN ~~Pharma~~PHARMA ~~Inc~~INC. (Exact name of registrant as specified in its charter)

(Exact name of registrant as specified in its charter)

Nevada		001-33715		20-2881151
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

6955 N Durango Drive, Las Vegas NV		89149
Suite 500 – 666 Burrard Street, Vancouver, BC		V6C 3P6
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (~~702~~778) ~~843~~558-~~0456~~7434

6955 N/A Durango Drive, Las Vegas NV 89149

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 15.~~01 Entry~~02 ~~into~~Departure ~~Material~~of ~~Definitive~~Directors ~~Agreement~~or Principal Officers; Election of Directors; Appointment of Principal Officers

On ~~March~~November 1014, ~~2013~~2014, ~~we entered into a purchase and sale agreement between~~ our ~~company,~~board ~~6708595~~of ~~Canada~~directors ~~Inc.,~~received ~~a Canada corporation~~ and ~~Kazem~~accepted ~~Agharazi. Pursuant to~~ the ~~agreement~~resignation ~~we have agreed to purchase all~~ of ~~the~~Moira ~~issued~~Ong ~~and~~as ~~outstanding~~our ~~shares~~chief offinancial ~~6708595~~officer, ~~Canada~~secretary and totreasurer. ~~purchase~~On ~~the~~November ~~right~~21, ~~title~~2014, ~~and~~our ~~interest~~board toof ~~assets~~directors ~~held~~received byand ~~Canadian~~accepted ~~Health Empire a sole proprietorship for which Kazem Agharazi is~~ the ~~sole~~resignation ~~proprietor. The assets consist~~ of 17Ahmed ~~natural~~Doroudian ~~health products marketed under brands such~~ as ~~O2,~~our ~~Zincola~~president, ~~Omega-3~~chief ~~Super~~executive ~~Krill~~officer ~~Oil, Bone Guard~~ and ~~Ironex~~director. ~~among~~On ~~others,~~November ~~for which we shall acquire the product registrations~~24, ~~trade marks~~2014, ~~starting~~our ~~material~~board ~~inventory,~~of ~~manufacturing~~directors ~~expertise,~~received ~~import/export permits~~ and ~~customer~~accepted ~~information~~the ~~required~~resignation toof ~~continue~~Patrick toCharles ~~sell~~Frankham ~~and~~as ~~market~~our ~~the products in various export markets~~director.

~~Item~~The ~~3.02 Unregistered~~resignations ~~Sales~~did ofnot ~~Equity~~result ~~Securities~~from any disagreements with our company regarding our operations, policies, practices or otherwise.

~~Effective~~On ~~March~~November 1321, 2014, we ~~issued~~appointed ~~110,000~~Dennis ~~shares~~Petke ~~of common stock in connection with the purchase and sale agreement to one non U.S. person (at that term~~ as ~~defined~~our inpresident, ~~Regulation~~chief Sexecutive ~~of the Securities Act of 1933)~~officer, ~~relying~~chief onfinancial ~~Regulation~~officer S and~~/or~~ ~~Section~~sole ~~4(2) of the Securities Act of 1933~~director.

~~Item~~Dennis ~~7.01 Regulation~~Petke FD– ~~Disclosure~~President and Director

OnMr. ~~March~~Petke ~~17,~~is ~~2014~~qualified as a Chartered Accountant in Canada, weand ~~issued~~is a ~~news~~member ~~release~~of ~~with~~the ~~respect~~Institute toof ~~the~~Chartered ~~purchase~~Accountants of British Columbia (1995). Currently serving as a director and/or ~~sale~~chief ~~agreement~~financial officer for a number of private and public companies, his responsibilities include strategic and overall financial management for these companies.

~~Item~~For 9the past five years, Mr.01 Petke has owned and operated Q4 Financial ~~Statements~~Group Inc., a private consulting firm serving both private and ~~Exhibits~~public companies in the areas of corporate finance, corporate administration and regulatory reporting. Mr. Petke has over 15 years experience in the financial services sector including facilitating the membership of a private BC securities firm with the Investment Dealers Association, negotiating and implementing private and public company mergers, as well as facilitating private placement, preference share, convertible debenture, special warrant and debt financings.

10.1		Purchase and Sale Agreement dated as of March 10, 2014
99.1		News Release dated March 17, 2014

Our company believes that Mr. Petke's professional background experience give him the qualifications and skills necessary to serve as a director of our company.

2Mr. Petke’s current plan is to maximize value from all assets to increase shareholder value.

~~SIGNATURES~~2

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~SIGNATURES

	VANSEN PHARMA INC.
Date: March 18, 2014	By:	/s/ Ahmad Doroudian
		Ahmad Doroudian
		President and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VANSEN PHARMA INC.

Date: March 27, 2015	By:	/s/ Dennis Petke
		Dennis Petke
		President and Director

Filing Compare · Vansen Pharma Inc.